0/G1期,抑制其增殖;對C-33-A細(xì)胞無顯著作用。顯著上調(diào)SiHa、HeLa細(xì)胞內(nèi)Cle caspase 3、Cle caspase 9、Bax表達(dá),下調(diào)Bcl-2表達(dá)(P<0.05、0.01、0.001)。結(jié)論 EPV可誘導(dǎo)HPV陽性人宮頸癌SiHa、HeLa細(xì)胞凋亡,對HPV陰性C-33-A細(xì)胞無顯著作用,為夏枯草及其制劑在臨床上治療宮頸癌提供依據(jù)。;Objective To study the potential apoptotic effect of extract from Prunella vulgaris (EPV), a traditional Chinese medicine, on human papilloma virus (HPV) positive and negative human cervical cancer cells. Methods Human cervical carcinoma cell lines SiHa, Hela (HPV positive), and C-33-A (HPV negative) were cultured, and treated with 20, 40, and 80 μg/mL of EPV for 24 h. Control group were treated with equal volume of DMSO. The survival rate of cells was detected by methyl thiazolyl tetrazolium (MTT) method. Flow cytometry Annexin V/PI double staining method was used to detect cell apoptosis and cell cycle. SiHa and HeLa cells were incubated with 40 μg/mL EPV for 24 h, and Western blotting was used to detect the expression of apoptosis related protein caspase 3, caspase 9, Bcl-2, and Bax. Results EPV reduced the viability of SiHa and HeLa cells dose-dependently (P<0.05, 0.01 and 0.001). Moreover, EPV induced apoptosis in SiHa and HeLa cells (P<0.05 and 0.01), inhibited the proliferation of SiHa and HeLa cells through arresting their cycle in G0/G1 phase. However, EPV did not show significantly effect on C-33-A cells. Western blotting results showed that Cle caspase 3, Cle caspase 9, Bax, and Bcl-2 proteins were involved in EPV induced cell apoptosis (P<0.05, 0.01, and 0.001). Conclusion EPV could induce apoptosis in HPV-positive cervical cancer cells, which provides novel information for clinical application of P. vulgaris and its preparations for the HPV-positive cervical cancer patients."/>

醉酒后少妇被疯狂内射视频,一本色道久久综合一,在线天堂新版资源www在线下载,中文字幕乱人伦高清视频,中字幕视频在线永久在线观看免费

首頁 > 過刊瀏覽>2016年第39卷第3期 >2016,39(3):388-393. DOI:10.7501/j.issn.1674-6376.2016.03.011
上一篇 | 下一篇

夏枯草提取物對人乳頭瘤病毒陽性宮頸癌細(xì)胞的凋亡作用

Apoptotic effect of extract from Prunella vulgaris on human papilloma virus positive cervical cancer cells

發(fā)布日期:2016-05-27
您是第位訪問者
藥物評價研究 ® 2025 版權(quán)所有
技術(shù)支持:北京勤云科技發(fā)展有限公司
津備案:津ICP備13000267號 互聯(lián)網(wǎng)藥品信息服務(wù)資格證書編號:(津)-非經(jīng)營性-2015-0031